Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $37 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper: Strong Sales Growth and Attractive Valuation Drive Buy Rating
- Keurig Dr Pepper Reports Strong Q2 2025 Results
- Keurig Dr Pepper’s Earnings Call Highlights Growth Amid Challenges
- Morning Movers: Dow Inc. falls following Q2 report and dividend cut
- Keurig Dr Pepper reports Q2 adjusted EPS 49c, consensus 49c